Skip to main content
. 2021 Sep;49(9):822–832. doi: 10.1124/dmd.120.000320

TABLE 4.

Summary of substrate and inhibitor data sets used in this study

Type Data Set Name Total Number of Compounds Number of Actives Number of Inactives Imbalance Ratio (Inactives/Actives)
Substrate data CYP2C9 3966 1126 2840 3:1
CYP2D6 3946 1318 2628 2:1
CYP3A4 3974 1883 2091 1:1
Inhibitor data CYP2C9 3288 570 2718 5:1
CYP2D6 3187 367 2820 8:1
CYP3A4 2794 340 2454 7:1